DUBLIN--(BUSINESS WIRE)--The "Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2017-2022" report has been added to ResearchAndMarkets.com's offering.
The global generic injectables market reached a value of more than US$ 43 Billion in 2016, exhibiting a CAGR of around 9% during 2009-2016.
Generic injectables are bio-equivalents of their branded counterparts which are not protected by drug patents. They are as safe and effective as the innovator drugs since they have similar active ingredient, dosage, strength, quality, form, etc. Although the manufacturing of generic injectables is complex, their R&D cycle is cheaper and shorter. Unlike branded drug manufacturers who spend millions of dollars on R&D and marketing, generic drug manufacturers do not require such investments.
The report has segmented the market on the basis of therapeutic area as oncology, anaesthesia, anti-infectives, parenteral nutrition, cardiovascular and others. Currently, the oncology segment accounts for the majority of the total market share. Further, the report has segmented the market on the basis of distribution channels covering hospitals and retail pharmacy stores. Among these, hospitals account for the largest market share.
On a regional basis, the report covers North America, Europe, Asia, Latin America, and Middle East and Africa. North America represents the largest region, accounting for more than a half of the total global share.
- Fresenius Kabi
- Hospira (Pfizer)
- Sandoz (Novartis)
Key Topics Covered:
2 Scope and Methodology
3 Executive Summary
5 Global Generic Drug Market
6 Global Generic Drug Delivery Market
7 Global Generic Injectables Market
8 Global Generic Injectables Market: Performance of Key Regions
9 Market by Therapeutic Area
10 Market by Distribution Channel
11 Global Generic Injectable Market: Competitive Landscape
12 Generic Injectable Manufacturing Process
13 Project Details, Requirements and Costs Involved
14 Loans and Financial Assistance
15 Project Economics
16 Key Player Profiles
For more information about this report visit https://www.researchandmarkets.com/research/ql3mcx/global_generic?w=4